Annual Total Debt:
$455.10M+$26.70M(+6.23%)Summary
- As of today (May 29, 2025), NBIX annual total debt is $455.10 million, with the most recent change of +$26.70 million (+6.23%) on December 31, 2024.
- During the last 3 years, NBIX annual total debt has risen by +$14.70 million (+3.34%).
- NBIX annual total debt is now -8.15% below its all-time high of $495.50 million, reached on December 31, 2019.
Performance
NBIX Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$447.50M-$7.60M(-1.67%)Summary
- As of today (May 29, 2025), NBIX quarterly total debt is $447.50 million, with the most recent change of -$7.60 million (-1.67%) on March 31, 2025.
- Over the past year, NBIX quarterly total debt has dropped by -$64.40 million (-12.58%).
- NBIX quarterly total debt is now -12.58% below its all-time high of $511.90 million, reached on March 31, 2024.
Performance
NBIX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
NBIX Total debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +6.2% | -12.6% |
3 y3 years | +3.3% | -6.8% |
5 y5 years | -8.2% | -10.4% |
NBIX Total debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +73.1% | -12.6% | +78.0% |
5 y | 5-year | -8.2% | +73.1% | -12.6% | +78.0% |
alltime | all time | -8.2% | >+9999.0% | -12.6% | >+9999.0% |
NBIX Total debt History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $447.50M(-1.7%) |
Dec 2024 | $455.10M(+6.2%) | $455.10M(+81.0%) |
Sep 2024 | - | $251.40M(-1.9%) |
Jun 2024 | - | $256.20M(-50.0%) |
Mar 2024 | - | $511.90M(+19.5%) |
Dec 2023 | $428.40M(+63.0%) | $428.40M(+56.6%) |
Sep 2023 | - | $273.60M(-1.0%) |
Jun 2023 | - | $276.50M(+6.4%) |
Mar 2023 | - | $259.90M(-1.1%) |
Dec 2022 | $262.90M(-40.3%) | $262.90M(-1.1%) |
Sep 2022 | - | $265.80M(-1.0%) |
Jun 2022 | - | $268.60M(-44.1%) |
Mar 2022 | - | $480.20M(+9.0%) |
Dec 2021 | $440.40M(+6.8%) | $440.40M(+0.8%) |
Sep 2021 | - | $437.10M(+0.4%) |
Jun 2021 | - | $435.30M(+1.4%) |
Mar 2021 | - | $429.50M(+4.2%) |
Dec 2020 | $412.30M(-16.8%) | $412.30M(-18.8%) |
Sep 2020 | - | $508.00M(+0.8%) |
Jun 2020 | - | $503.80M(+0.8%) |
Mar 2020 | - | $499.70M(+0.8%) |
Dec 2019 | $495.50M(+27.5%) | $495.50M(+3.6%) |
Sep 2019 | - | $478.07M(+2.9%) |
Jun 2019 | - | $464.65M(+0.9%) |
Mar 2019 | - | $460.58M(+18.6%) |
Dec 2018 | $388.50M(+5.1%) | $388.50M(+1.3%) |
Sep 2018 | - | $383.65M(+1.3%) |
Jun 2018 | - | $378.88M(+1.2%) |
Mar 2018 | - | $374.21M(+1.2%) |
Dec 2017 | $369.62M(>+9900.0%) | $369.62M(+1.2%) |
Sep 2017 | - | $365.11M(+1.2%) |
Jun 2017 | - | $360.68M(>+9900.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2016 | - | $0.00(0.0%) |
Jun 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2015 | - | $0.00(0.0%) |
Jun 2015 | - | $0.00(0.0%) |
Mar 2015 | - | $0.00(0.0%) |
Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2014 | - | $0.00(0.0%) |
Jun 2014 | - | $0.00(0.0%) |
Mar 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2013 | - | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) |
Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2012 | - | $0.00(0.0%) |
Jun 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00(0.0%) |
Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2011 | - | $0.00(0.0%) |
Jun 2011 | - | $0.00(0.0%) |
Mar 2011 | - | $0.00(0.0%) |
Dec 2010 | $0.00 | $0.00(-100.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | $8.53M(-10.6%) |
Jun 2010 | - | $9.54M(-9.4%) |
Mar 2010 | - | $10.53M(>+9900.0%) |
Dec 2009 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2009 | - | $17.28M(-4.9%) |
Jun 2009 | - | $18.16M(-0.3%) |
Mar 2009 | - | $18.22M(+18.3%) |
Dec 2008 | $15.40M(+936.1%) | $15.40M(+5478.6%) |
Sep 2008 | - | $276.00K(-54.1%) |
Jun 2008 | - | $601.00K(-41.4%) |
Mar 2008 | - | $1.02M(-31.0%) |
Dec 2007 | $1.49M(-97.2%) | $1.49M(-97.0%) |
Sep 2007 | - | $50.13M(-2.1%) |
Jun 2007 | - | $51.20M(-2.3%) |
Mar 2007 | - | $52.40M(-2.3%) |
Dec 2006 | $53.64M(-9.7%) | $53.64M(-2.5%) |
Sep 2006 | - | $54.99M(-2.6%) |
Jun 2006 | - | $56.45M(-2.6%) |
Mar 2006 | - | $57.95M(-2.4%) |
Dec 2005 | $59.40M(-10.2%) | $59.40M(-2.6%) |
Sep 2005 | - | $60.99M(-2.6%) |
Jun 2005 | - | $62.63M(-2.8%) |
Mar 2005 | - | $64.41M(-2.6%) |
Dec 2004 | $66.13M(+81.5%) | $66.13M(-3.7%) |
Sep 2004 | - | $68.70M(+16.7%) |
Jun 2004 | - | $58.88M(+24.9%) |
Mar 2004 | - | $47.13M(+29.4%) |
Dec 2003 | $36.43M(+359.1%) | $36.43M(+61.7%) |
Sep 2003 | - | $22.53M(+0.3%) |
Jun 2003 | - | $22.47M(+170.6%) |
Mar 2003 | - | $8.30M(+4.6%) |
Dec 2002 | $7.93M(+39.5%) | $7.93M(+18.6%) |
Sep 2002 | - | $6.69M(+19.6%) |
Jun 2002 | - | $5.59M(+9.3%) |
Mar 2002 | - | $5.12M(-10.1%) |
Dec 2001 | $5.69M(+47.0%) | $5.69M(+52.2%) |
Sep 2001 | - | $3.74M(-10.3%) |
Jun 2001 | - | $4.16M(+18.2%) |
Mar 2001 | - | $3.52M(-8.9%) |
Dec 2000 | $3.87M(+24.8%) | $3.87M(+26.6%) |
Sep 2000 | - | $3.06M(+16.1%) |
Jun 2000 | - | $2.63M(-8.4%) |
Mar 2000 | - | $2.87M(-7.3%) |
Dec 1999 | $3.10M(+3.3%) | $3.10M(0.0%) |
Sep 1999 | - | $3.10M(+34.8%) |
Jun 1999 | - | $2.30M(-36.1%) |
Mar 1999 | - | $3.60M(+20.0%) |
Dec 1998 | $3.00M(+87.5%) | $3.00M(>+9900.0%) |
Sep 1998 | - | $0.00(0.0%) |
Jun 1998 | - | $0.00(0.0%) |
Mar 1998 | - | $0.00(-100.0%) |
Dec 1997 | $1.60M(0.0%) | $1.60M(>+9900.0%) |
Sep 1997 | - | $0.00(0.0%) |
Jun 1997 | - | $0.00(0.0%) |
Mar 1997 | - | $0.00(-100.0%) |
Dec 1996 | $1.60M | $1.60M(>+9900.0%) |
Sep 1996 | - | $0.00(0.0%) |
Jun 1996 | - | $0.00(-100.0%) |
Mar 1996 | - | $2.20M |
FAQ
- What is Neurocrine Biosciences annual total debt?
- What is the all time high annual total debt for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual total debt year-on-year change?
- What is Neurocrine Biosciences quarterly total debt?
- What is the all time high quarterly total debt for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly total debt year-on-year change?
What is Neurocrine Biosciences annual total debt?
The current annual total debt of NBIX is $455.10M
What is the all time high annual total debt for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual total debt is $495.50M
What is Neurocrine Biosciences annual total debt year-on-year change?
Over the past year, NBIX annual total debt has changed by +$26.70M (+6.23%)
What is Neurocrine Biosciences quarterly total debt?
The current quarterly total debt of NBIX is $447.50M
What is the all time high quarterly total debt for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly total debt is $511.90M
What is Neurocrine Biosciences quarterly total debt year-on-year change?
Over the past year, NBIX quarterly total debt has changed by -$64.40M (-12.58%)